Kathleen Borthwick, SVP, INTERIM CFO at Passage BIO, Inc. (PASG), sold 1,470 shares at $0.97 ($1K) on 2024-02-13, disclosed to the SEC on 2024-02-13.
Open-market sale of $1k PASG by SVP, INTERIM CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| PASG | SELL | 2024-01-03 | $10K | — | Filing → |